Senior insider sale
Chief Commercial Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.34M
314.06K shares
What this filing means
KARAS ERIC plans to sell 314.06K shares of ARS PHARMACEUTICALS, INC. valued at approximately $1.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/19/2026ACC: 0001950047-26-010301
Officer· Chief Commercial Officer
Since Nov 2022
314.06K
Shares to sell
$1.34M
Approx. market value
100K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/19/2026
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/19/2026 | Stock Option Exercise Cash | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
100K
Market value
$426.1K
10/1/2026
—Completed
Units to sell
100K
Market value
$431.6K
9/30/2026
—Completed
Units to sell
14.06K
Market value
$69.8K
9/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
100K
Market value
$410.2K
10/19/2026
Total
Units
314.06K
Value
$1.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/1/2026 | 100K | $426.1K | — | Completed |
9/30/2026 | 100K | $431.6K | — | Completed |
9/11/2026 | 14.06K | $69.8K | — | Completed |
| Planned — Approximate Date | ||||
10/19/2026 | 100K | $410.2K | NASDAQ | Planned |
| Total | 314.06K | $1.34M | ||